

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 6.07867332 |
| 2 | actin-myosin filament sliding (GO:0033275) | 6.07867332 |
| 3 | regulation of relaxation of muscle (GO:1901077) | 5.59047776 |
| 4 | actin-mediated cell contraction (GO:0070252) | 5.36567743 |
| 5 | purine nucleotide salvage (GO:0032261) | 5.10414937 |
| 6 | adenosine metabolic process (GO:0046085) | 4.95351208 |
| 7 | polyketide metabolic process (GO:0030638) | 4.84270244 |
| 8 | doxorubicin metabolic process (GO:0044598) | 4.84270244 |
| 9 | daunorubicin metabolic process (GO:0044597) | 4.84270244 |
| 10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.54603451 |
| 11 | tryptophan catabolic process (GO:0006569) | 4.51070124 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 4.51070124 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 4.51070124 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 4.40164663 |
| 15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.39433137 |
| 16 | amine catabolic process (GO:0009310) | 4.32911390 |
| 17 | cellular biogenic amine catabolic process (GO:0042402) | 4.32911390 |
| 18 | cell wall macromolecule metabolic process (GO:0044036) | 4.29332828 |
| 19 | tryptophan metabolic process (GO:0006568) | 4.29039418 |
| 20 | skeletal muscle contraction (GO:0003009) | 4.15717268 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.02490692 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 3.96746175 |
| 23 | purine-containing compound salvage (GO:0043101) | 3.95637169 |
| 24 | oxidative phosphorylation (GO:0006119) | 3.90482941 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.82259979 |
| 26 | actin filament-based movement (GO:0030048) | 3.80765251 |
| 27 | detection of molecule of bacterial origin (GO:0032490) | 3.75996860 |
| 28 | myofibril assembly (GO:0030239) | 3.66155727 |
| 29 | ether lipid metabolic process (GO:0046485) | 3.65891160 |
| 30 | NADH metabolic process (GO:0006734) | 3.59422212 |
| 31 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.58762345 |
| 32 | indolalkylamine metabolic process (GO:0006586) | 3.52844223 |
| 33 | creatine metabolic process (GO:0006600) | 3.50333753 |
| 34 | striated muscle contraction (GO:0006941) | 3.47737262 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 3.47164119 |
| 36 | cellular hyperosmotic response (GO:0071474) | 3.46347348 |
| 37 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.44246778 |
| 38 | inner mitochondrial membrane organization (GO:0007007) | 3.42149355 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.38659336 |
| 40 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37422983 |
| 41 | carnitine shuttle (GO:0006853) | 3.36598261 |
| 42 | interkinetic nuclear migration (GO:0022027) | 3.36185057 |
| 43 | sarcomere organization (GO:0045214) | 3.35236070 |
| 44 | negative regulation of mast cell activation (GO:0033004) | 3.35124440 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.35077211 |
| 46 | polysaccharide catabolic process (GO:0000272) | 3.34988639 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.32735379 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 3.32735379 |
| 49 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.31539286 |
| 50 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.29349686 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.26650498 |
| 52 | toxin transport (GO:1901998) | 3.20905466 |
| 53 | regulation of sequestering of triglyceride (GO:0010889) | 3.19947287 |
| 54 | response to hydroperoxide (GO:0033194) | 3.19410024 |
| 55 | glucan biosynthetic process (GO:0009250) | 3.16295990 |
| 56 | glycogen biosynthetic process (GO:0005978) | 3.16295990 |
| 57 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14607171 |
| 58 | valine metabolic process (GO:0006573) | 3.13934132 |
| 59 | positive regulation of chemokine secretion (GO:0090197) | 3.13909673 |
| 60 | hepatocyte apoptotic process (GO:0097284) | 3.12878798 |
| 61 | regulation of B cell apoptotic process (GO:0002902) | 3.11316190 |
| 62 | glucosamine-containing compound catabolic process (GO:1901072) | 3.10085616 |
| 63 | homocysteine metabolic process (GO:0050667) | 3.08442344 |
| 64 | positive regulation of macrophage cytokine production (GO:0060907) | 3.07047990 |
| 65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.05881608 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.02544684 |
| 67 | acylglycerol homeostasis (GO:0055090) | 3.02544684 |
| 68 | ubiquinone biosynthetic process (GO:0006744) | 3.02442986 |
| 69 | AMP metabolic process (GO:0046033) | 3.01339216 |
| 70 | superoxide anion generation (GO:0042554) | 3.00062798 |
| 71 | negative regulation of lipase activity (GO:0060192) | 2.98874648 |
| 72 | NAD biosynthetic process (GO:0009435) | 2.98185490 |
| 73 | ubiquinone metabolic process (GO:0006743) | 2.95523108 |
| 74 | nucleotide transmembrane transport (GO:1901679) | 2.94149924 |
| 75 | response to muscle activity (GO:0014850) | 2.94069478 |
| 76 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.93932909 |
| 77 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.93507707 |
| 78 | L-phenylalanine metabolic process (GO:0006558) | 2.93507707 |
| 79 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.93258852 |
| 80 | regulation of actin filament-based movement (GO:1903115) | 2.92909772 |
| 81 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.92031566 |
| 82 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.92013406 |
| 83 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.92013406 |
| 84 | histone mRNA catabolic process (GO:0071044) | 2.91549432 |
| 85 | glyoxylate metabolic process (GO:0046487) | 2.89583095 |
| 86 | cardiac muscle contraction (GO:0060048) | 2.89178841 |
| 87 | cardiac muscle hypertrophy (GO:0003300) | 2.85829012 |
| 88 | cardiac myofibril assembly (GO:0055003) | 2.85363875 |
| 89 | reverse cholesterol transport (GO:0043691) | 2.85253471 |
| 90 | detection of external biotic stimulus (GO:0098581) | 2.84272387 |
| 91 | protein carboxylation (GO:0018214) | 2.81946849 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.81946849 |
| 93 | aromatic amino acid family metabolic process (GO:0009072) | 2.81223640 |
| 94 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.81171141 |
| 95 | phospholipid efflux (GO:0033700) | 2.78946276 |
| 96 | carnitine transmembrane transport (GO:1902603) | 2.77557904 |
| 97 | protein-lipid complex remodeling (GO:0034368) | 2.75083023 |
| 98 | macromolecular complex remodeling (GO:0034367) | 2.75083023 |
| 99 | plasma lipoprotein particle remodeling (GO:0034369) | 2.75083023 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.74621686 |
| 101 | amino-acid betaine transport (GO:0015838) | 2.73377627 |
| 102 | carnitine transport (GO:0015879) | 2.73377627 |
| 103 | regulation of triglyceride catabolic process (GO:0010896) | 2.73327966 |
| 104 | mRNA modification (GO:0016556) | 2.72390435 |
| 105 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.71806047 |
| 106 | cellular glucuronidation (GO:0052695) | 2.71451370 |
| 107 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.71209030 |
| 108 | striated muscle hypertrophy (GO:0014897) | 2.71193474 |
| 109 | urea cycle (GO:0000050) | 2.71181482 |
| 110 | urea metabolic process (GO:0019627) | 2.71181482 |
| 111 | cellular anion homeostasis (GO:0030002) | 2.70909267 |
| 112 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.69340991 |
| 113 | omega-hydroxylase P450 pathway (GO:0097267) | 2.68519603 |
| 114 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.68483283 |
| 115 | cholesterol efflux (GO:0033344) | 2.67927380 |
| 116 | aggressive behavior (GO:0002118) | 2.67478117 |
| 117 | growth hormone receptor signaling pathway (GO:0060396) | 2.66760070 |
| 118 | coenzyme catabolic process (GO:0009109) | 2.66516451 |
| 119 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65882318 |
| 120 | response to inactivity (GO:0014854) | 2.63403893 |
| 121 | glucan catabolic process (GO:0009251) | 2.63342269 |
| 122 | regulation of cholesterol esterification (GO:0010872) | 2.62927808 |
| 123 | purine ribonucleotide transport (GO:0015868) | 2.62808644 |
| 124 | auditory receptor cell stereocilium organization (GO:0060088) | 2.62239833 |
| 125 | regulation of macrophage cytokine production (GO:0010935) | 2.62085982 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 2.61860179 |
| 127 | sulfate transmembrane transport (GO:1902358) | 2.60866576 |
| 128 | glycogen catabolic process (GO:0005980) | 2.60497606 |
| 129 | B cell mediated immunity (GO:0019724) | 2.60261651 |
| 130 | regulation of chemokine secretion (GO:0090196) | 2.59865724 |
| 131 | prostate gland growth (GO:0060736) | 2.59809882 |
| 132 | complement activation, alternative pathway (GO:0006957) | 2.59025868 |
| 133 | phospholipid homeostasis (GO:0055091) | 2.58896399 |
| 134 | response to epinephrine (GO:0071871) | 2.58889913 |
| 135 | tyrosine metabolic process (GO:0006570) | 2.58262375 |
| 136 | cellular polysaccharide catabolic process (GO:0044247) | 2.57667182 |
| 137 | oxaloacetate metabolic process (GO:0006107) | 2.57320532 |
| 138 | peroxisome fission (GO:0016559) | 2.56396448 |
| 139 | negative regulation of B cell proliferation (GO:0030889) | 2.56319272 |
| 140 | GPI anchor biosynthetic process (GO:0006506) | 2.56276640 |
| 141 | bile acid biosynthetic process (GO:0006699) | 2.56201476 |
| 142 | cellular response to epinephrine stimulus (GO:0071872) | 2.56082486 |
| 143 | uronic acid metabolic process (GO:0006063) | 2.55747347 |
| 144 | glucuronate metabolic process (GO:0019585) | 2.55747347 |
| 145 | bile acid metabolic process (GO:0008206) | 2.55307534 |
| 146 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.54932413 |
| 147 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.54932413 |
| 148 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.54034427 |
| 149 | drug catabolic process (GO:0042737) | 2.53690868 |
| 150 | phagocytosis, recognition (GO:0006910) | 2.53339190 |
| 151 | muscle hypertrophy (GO:0014896) | 2.53215487 |
| 152 | skeletal muscle adaptation (GO:0043501) | 2.53061381 |
| 153 | androgen metabolic process (GO:0008209) | 2.52545704 |
| 154 | microglial cell activation (GO:0001774) | 2.52487713 |
| 155 | detection of biotic stimulus (GO:0009595) | 2.52134820 |
| 156 | regulation of sarcomere organization (GO:0060297) | 2.51799110 |
| 157 | adult heart development (GO:0007512) | 2.50874236 |
| 158 | energy homeostasis (GO:0097009) | 2.50486167 |
| 159 | response to host immune response (GO:0052572) | 2.50362857 |
| 160 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50362857 |
| 161 | bile acid and bile salt transport (GO:0015721) | 2.50255861 |
| 162 | positive thymic T cell selection (GO:0045059) | 2.50156505 |
| 163 | extracellular negative regulation of signal transduction (GO:1900116) | 2.49815157 |
| 164 | extracellular regulation of signal transduction (GO:1900115) | 2.49815157 |
| 165 | cellular response to growth hormone stimulus (GO:0071378) | 2.49698084 |
| 166 | inner ear receptor stereocilium organization (GO:0060122) | 2.49553896 |
| 167 | proteasome assembly (GO:0043248) | 2.49512932 |
| 168 | polyol transport (GO:0015791) | 2.48513611 |
| 169 | regulation of activation of Janus kinase activity (GO:0010533) | 2.47928183 |
| 170 | purine nucleotide transport (GO:0015865) | 2.46120458 |
| 171 | DNA demethylation (GO:0080111) | 2.45194889 |
| 172 | opsonization (GO:0008228) | 2.43253523 |
| 173 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.43029091 |
| 174 | trivalent inorganic anion homeostasis (GO:0072506) | 2.42715480 |
| 175 | phosphate ion homeostasis (GO:0055062) | 2.42715480 |
| 176 | branched-chain amino acid catabolic process (GO:0009083) | 2.41539254 |
| 177 | low-density lipoprotein particle remodeling (GO:0034374) | 2.41170751 |
| 178 | fatty acid beta-oxidation (GO:0006635) | 2.40929804 |
| 179 | nitrogen cycle metabolic process (GO:0071941) | 2.40087464 |
| 180 | adenine nucleotide transport (GO:0051503) | 2.37375167 |
| 181 | lipid oxidation (GO:0034440) | 2.36887271 |
| 182 | fatty acid oxidation (GO:0019395) | 2.36848648 |
| 183 | biotin metabolic process (GO:0006768) | 2.36117016 |
| 184 | cell differentiation involved in metanephros development (GO:0072202) | 2.34190465 |
| 185 | plasma lipoprotein particle organization (GO:0071827) | 2.32749703 |
| 186 | branched-chain amino acid metabolic process (GO:0009081) | 2.31748918 |
| 187 | plasma lipoprotein particle clearance (GO:0034381) | 2.30476866 |
| 188 | regulation of protein activation cascade (GO:2000257) | 2.30188674 |
| 189 | alpha-amino acid catabolic process (GO:1901606) | 2.29448552 |
| 190 | exogenous drug catabolic process (GO:0042738) | 2.29354684 |
| 191 | linoleic acid metabolic process (GO:0043651) | 2.29253989 |
| 192 | regulation of bile acid biosynthetic process (GO:0070857) | 2.27944232 |
| 193 | nucleotide transport (GO:0006862) | 2.27623743 |
| 194 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.25158324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80471373 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24722211 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.98071680 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56729711 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.39718920 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34480048 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.33226689 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32266020 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.28907412 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.26236459 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.26038593 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.13524318 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.12611989 |
| 14 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.04813075 |
| 15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.01094583 |
| 16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.00632850 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.99632054 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.91462391 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.91206065 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90568969 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87647886 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86963552 |
| 23 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86645002 |
| 24 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.85694111 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.85515503 |
| 26 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.85242453 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.84129894 |
| 28 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.83748859 |
| 29 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.80764704 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.80615477 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80530754 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77434262 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.76764246 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75977330 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75408039 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74281875 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72627460 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70583376 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68224409 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.65040237 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64476514 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64220634 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.63413408 |
| 44 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.62650029 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61654962 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58869734 |
| 47 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.58197503 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58120883 |
| 49 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.56231184 |
| 50 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.55359355 |
| 51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.54953331 |
| 52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.54395517 |
| 53 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.53647858 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.52674877 |
| 55 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.50852648 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49598462 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.49119915 |
| 58 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45044277 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.44540316 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43441603 |
| 61 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.43069612 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41765005 |
| 63 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.40725772 |
| 64 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.40290763 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.40251698 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39191728 |
| 67 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38317248 |
| 68 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37371135 |
| 69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36476493 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36255591 |
| 71 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.35532841 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35345549 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34960759 |
| 74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34608125 |
| 75 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34573931 |
| 76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33730562 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.33544361 |
| 78 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.33502896 |
| 79 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.33262660 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.33227682 |
| 81 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.33147241 |
| 82 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.31806927 |
| 83 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31083138 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.30875220 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30729685 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.30083684 |
| 87 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29640062 |
| 88 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.29062590 |
| 89 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.29017968 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27525923 |
| 91 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.27397907 |
| 92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27325086 |
| 93 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.26026880 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.25822290 |
| 95 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25770314 |
| 96 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25710951 |
| 97 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.25287086 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.25147042 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24855996 |
| 100 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.24527514 |
| 101 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.23471751 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23458344 |
| 103 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23122841 |
| 104 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.21773890 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.21545018 |
| 106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.21545018 |
| 107 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.21381205 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21285458 |
| 109 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20962299 |
| 110 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.20945112 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20600545 |
| 112 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.19424063 |
| 113 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.19164070 |
| 114 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.19164070 |
| 115 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.18968816 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18719919 |
| 117 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18466995 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18073632 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16860580 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16572204 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16354136 |
| 122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16147869 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15955072 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15697270 |
| 125 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14347396 |
| 126 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14347396 |
| 127 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.14042522 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13950206 |
| 129 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.12940459 |
| 130 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12841796 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12797896 |
| 132 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12634206 |
| 133 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12559863 |
| 134 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12412978 |
| 135 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12328582 |
| 136 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.12221467 |
| 137 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.11480171 |
| 138 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.10868307 |
| 139 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.10167455 |
| 140 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10112262 |
| 141 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.09827109 |
| 142 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09770117 |
| 143 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09371588 |
| 144 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06884991 |
| 145 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06549557 |
| 146 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.06516501 |
| 147 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04909677 |
| 148 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04204650 |
| 149 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03094833 |
| 150 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03094833 |
| 151 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03067549 |
| 152 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99784119 |
| 153 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99024277 |
| 154 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98864689 |
| 155 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97844072 |
| 156 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96353123 |
| 157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96176231 |
| 158 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.95667930 |
| 159 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95414704 |
| 160 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94680246 |
| 161 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94023128 |
| 162 | MYB_26560356_Chip-Seq_TH2_Human | 0.93842473 |
| 163 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93490471 |
| 164 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93476586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.41418979 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.43109791 |
| 3 | MP0005360_urolithiasis | 4.26345479 |
| 4 | MP0005365_abnormal_bile_salt | 3.94060669 |
| 5 | MP0000566_synostosis | 3.90692213 |
| 6 | MP0005670_abnormal_white_adipose | 3.81930997 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.79492904 |
| 8 | MP0004084_abnormal_cardiac_muscle | 3.68408465 |
| 9 | MP0003646_muscle_fatigue | 3.57792867 |
| 10 | MP0009697_abnormal_copulation | 3.48383433 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.21648256 |
| 12 | MP0004036_abnormal_muscle_relaxation | 3.06404913 |
| 13 | MP0004147_increased_porphyrin_level | 3.01150458 |
| 14 | MP0003252_abnormal_bile_duct | 2.98570213 |
| 15 | MP0004145_abnormal_muscle_electrophysio | 2.88959840 |
| 16 | MP0000749_muscle_degeneration | 2.83680308 |
| 17 | MP0005451_abnormal_body_composition | 2.59394325 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.47439014 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.46496686 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.42818008 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.36702336 |
| 22 | MP0003195_calcinosis | 2.30338555 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.13776785 |
| 24 | MP0004484_altered_response_of | 2.08642541 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 2.05981076 |
| 26 | MP0006054_spinal_hemorrhage | 2.04145668 |
| 27 | MP0002876_abnormal_thyroid_physiology | 1.99279189 |
| 28 | MP0000751_myopathy | 1.97862044 |
| 29 | MP0002102_abnormal_ear_morphology | 1.88428571 |
| 30 | MP0004215_abnormal_myocardial_fiber | 1.87790378 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.86559318 |
| 32 | MP0004381_abnormal_hair_follicle | 1.84724521 |
| 33 | MP0006292_abnormal_olfactory_placode | 1.83789656 |
| 34 | MP0005171_absent_coat_pigmentation | 1.79831744 |
| 35 | MP0002332_abnormal_exercise_endurance | 1.75476478 |
| 36 | MP0005620_abnormal_muscle_contractility | 1.74766593 |
| 37 | MP0002106_abnormal_muscle_physiology | 1.73456228 |
| 38 | MP0005266_abnormal_metabolism | 1.68931280 |
| 39 | MP0005332_abnormal_amino_acid | 1.66417150 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.63807669 |
| 41 | MP0002972_abnormal_cardiac_muscle | 1.63049319 |
| 42 | MP0003136_yellow_coat_color | 1.61873574 |
| 43 | MP0009764_decreased_sensitivity_to | 1.61583212 |
| 44 | MP0005330_cardiomyopathy | 1.60060211 |
| 45 | MP0004087_abnormal_muscle_fiber | 1.58931972 |
| 46 | MP0008995_early_reproductive_senescence | 1.56779141 |
| 47 | MP0002269_muscular_atrophy | 1.55950296 |
| 48 | MP0001188_hyperpigmentation | 1.48114770 |
| 49 | MP0008004_abnormal_stomach_pH | 1.47281855 |
| 50 | MP0004782_abnormal_surfactant_physiolog | 1.46974067 |
| 51 | MP0003941_abnormal_skin_development | 1.46604682 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.46516567 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.46071492 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.45758011 |
| 55 | MP0005647_abnormal_sex_gland | 1.41816014 |
| 56 | MP0008775_abnormal_heart_ventricle | 1.41423506 |
| 57 | MP0003724_increased_susceptibility_to | 1.41207504 |
| 58 | MP0005248_abnormal_Harderian_gland | 1.41048297 |
| 59 | MP0005671_abnormal_response_to | 1.39801885 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.39718229 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.38386730 |
| 62 | MP0005369_muscle_phenotype | 1.36198397 |
| 63 | MP0000759_abnormal_skeletal_muscle | 1.36101588 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.35900030 |
| 65 | MP0008057_abnormal_DNA_replication | 1.32813704 |
| 66 | MP0005503_abnormal_tendon_morphology | 1.29730141 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.28523815 |
| 68 | MP0004742_abnormal_vestibular_system | 1.27580927 |
| 69 | MP0001764_abnormal_homeostasis | 1.27384077 |
| 70 | MP0000747_muscle_weakness | 1.27249631 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.27247882 |
| 72 | MP0003868_abnormal_feces_composition | 1.27032644 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 1.24806880 |
| 74 | MP0004233_abnormal_muscle_weight | 1.24236133 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 1.24083441 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.22422223 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.22422223 |
| 78 | MP0004883_abnormal_blood_vessel | 1.21817936 |
| 79 | MP0005409_darkened_coat_color | 1.20784570 |
| 80 | MP0002132_abnormal_respiratory_system | 1.18954298 |
| 81 | MP0001544_abnormal_cardiovascular_syste | 1.18894750 |
| 82 | MP0005385_cardiovascular_system_phenoty | 1.18894750 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.18467353 |
| 84 | MP0010630_abnormal_cardiac_muscle | 1.18221876 |
| 85 | MP0003011_delayed_dark_adaptation | 1.17848932 |
| 86 | MP0010386_abnormal_urinary_bladder | 1.16217815 |
| 87 | MP0001800_abnormal_humoral_immune | 1.15558316 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12919519 |
| 89 | MP0002249_abnormal_larynx_morphology | 1.12510960 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 1.11576427 |
| 91 | MP0008058_abnormal_DNA_repair | 1.11050589 |
| 92 | MP0006035_abnormal_mitochondrial_morpho | 1.06267055 |
| 93 | MP0001324_abnormal_eye_pigmentation | 1.04915352 |
| 94 | MP0009384_cardiac_valve_regurgitation | 1.03348786 |
| 95 | MP0000372_irregular_coat_pigmentation | 1.02697153 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 1.00527025 |
| 97 | MP0005187_abnormal_penis_morphology | 1.00223259 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.98650368 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.98253984 |
| 100 | MP0000026_abnormal_inner_ear | 0.97739731 |
| 101 | MP0000427_abnormal_hair_cycle | 0.95912888 |
| 102 | MP0005334_abnormal_fat_pad | 0.95399357 |
| 103 | MP0000609_abnormal_liver_physiology | 0.94475310 |
| 104 | MP0005377_hearing/vestibular/ear_phenot | 0.93820799 |
| 105 | MP0003878_abnormal_ear_physiology | 0.93820799 |
| 106 | MP0005257_abnormal_intraocular_pressure | 0.93561389 |
| 107 | MP0003045_fibrosis | 0.93174133 |
| 108 | MP0002938_white_spotting | 0.91971307 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.89252220 |
| 110 | MP0002928_abnormal_bile_duct | 0.88573850 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.87921250 |
| 112 | MP0006276_abnormal_autonomic_nervous | 0.87754708 |
| 113 | MP0000516_abnormal_urinary_system | 0.86465211 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.86465211 |
| 115 | MP0008438_abnormal_cutaneous_collagen | 0.85531005 |
| 116 | MP0006138_congestive_heart_failure | 0.85470339 |
| 117 | MP0001661_extended_life_span | 0.84984058 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.84438581 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.84364310 |
| 120 | MP0002452_abnormal_antigen_presenting | 0.83356172 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.82743035 |
| 122 | MP0001502_abnormal_circadian_rhythm | 0.82618104 |
| 123 | MP0004130_abnormal_muscle_cell | 0.82188779 |
| 124 | MP0003186_abnormal_redox_activity | 0.81976366 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.81617859 |
| 126 | MP0002971_abnormal_brown_adipose | 0.81011034 |
| 127 | MP0000383_abnormal_hair_follicle | 0.80678723 |
| 128 | MP0002419_abnormal_innate_immunity | 0.79771680 |
| 129 | MP0002723_abnormal_immune_serum | 0.79442522 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.78492613 |
| 131 | MP0000049_abnormal_middle_ear | 0.78390860 |
| 132 | MP0010234_abnormal_vibrissa_follicle | 0.78029708 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.77479719 |
| 134 | MP0001346_abnormal_lacrimal_gland | 0.77304310 |
| 135 | MP0009115_abnormal_fat_cell | 0.76417909 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.76316115 |
| 137 | MP0002168_other_aberrant_phenotype | 0.75859672 |
| 138 | MP0008007_abnormal_cellular_replicative | 0.75707832 |
| 139 | MP0010352_gastrointestinal_tract_polyps | 0.75443010 |
| 140 | MP0000733_abnormal_muscle_development | 0.74173018 |
| 141 | MP0003828_pulmonary_edema | 0.73660808 |
| 142 | MP0010307_abnormal_tumor_latency | 0.73624383 |
| 143 | MP0005253_abnormal_eye_physiology | 0.72713733 |
| 144 | MP0003690_abnormal_glial_cell | 0.71792279 |
| 145 | MP0009763_increased_sensitivity_to | 0.70713717 |
| 146 | MP0000750_abnormal_muscle_regeneration | 0.70041454 |
| 147 | MP0009785_altered_susceptibility_to | 0.69616428 |
| 148 | MP0000015_abnormal_ear_pigmentation | 0.69481921 |
| 149 | MP0005083_abnormal_biliary_tract | 0.69330717 |
| 150 | MP0005508_abnormal_skeleton_morphology | 0.67301335 |
| 151 | MP0001790_abnormal_immune_system | 0.67177672 |
| 152 | MP0005387_immune_system_phenotype | 0.67177672 |
| 153 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66832403 |
| 154 | MP0000689_abnormal_spleen_morphology | 0.66621057 |
| 155 | MP0002148_abnormal_hypersensitivity_rea | 0.65940667 |
| 156 | MP0000163_abnormal_cartilage_morphology | 0.65933321 |
| 157 | MP0003191_abnormal_cellular_cholesterol | 0.64591940 |
| 158 | MP0000013_abnormal_adipose_tissue | 0.64187316 |
| 159 | MP0002060_abnormal_skin_morphology | 0.64027804 |
| 160 | MP0008469_abnormal_protein_level | 0.63845104 |
| 161 | MP0005000_abnormal_immune_tolerance | 0.63096851 |
| 162 | MP0003787_abnormal_imprinting | 0.63048258 |
| 163 | MP0009643_abnormal_urine_homeostasis | 0.62871897 |
| 164 | MP0001186_pigmentation_phenotype | 0.62839921 |
| 165 | MP0008260_abnormal_autophagy | 0.59645950 |
| 166 | MP0002108_abnormal_muscle_morphology | 0.58757757 |
| 167 | MP0009840_abnormal_foam_cell | 0.58156288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 7.45665522 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 7.37393452 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.16023407 |
| 4 | Exercise-induced myalgia (HP:0003738) | 5.40864165 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 5.16476575 |
| 6 | Rhabdomyolysis (HP:0003201) | 4.52870342 |
| 7 | Renal cortical cysts (HP:0000803) | 4.34335269 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.17898422 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.15856143 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.09601698 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.98253061 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.96426685 |
| 13 | Distal arthrogryposis (HP:0005684) | 3.89230042 |
| 14 | Myoglobinuria (HP:0002913) | 3.89015304 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.76239003 |
| 16 | Alopecia of scalp (HP:0002293) | 3.64158982 |
| 17 | Joint hemorrhage (HP:0005261) | 3.60850354 |
| 18 | Abnormality of glycolysis (HP:0004366) | 3.58541930 |
| 19 | Chronic hepatic failure (HP:0100626) | 3.49516452 |
| 20 | Subaortic stenosis (HP:0001682) | 3.43322210 |
| 21 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.43322210 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39892137 |
| 23 | Follicular hyperkeratosis (HP:0007502) | 3.29111754 |
| 24 | Vascular calcification (HP:0004934) | 3.26469062 |
| 25 | Sudden death (HP:0001699) | 3.26418763 |
| 26 | Muscle fiber splitting (HP:0003555) | 3.25479254 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.14973450 |
| 28 | Osteomalacia (HP:0002749) | 3.10632192 |
| 29 | Abnormality of the calf musculature (HP:0001430) | 3.07446802 |
| 30 | Congenital stationary night blindness (HP:0007642) | 3.07208117 |
| 31 | Abnormality of incisor morphology (HP:0011063) | 3.05914465 |
| 32 | Cardiovascular calcification (HP:0011915) | 3.00512460 |
| 33 | Facial diplegia (HP:0001349) | 2.99942416 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 2.97257730 |
| 35 | Areflexia of lower limbs (HP:0002522) | 2.96867816 |
| 36 | Rimmed vacuoles (HP:0003805) | 2.94909860 |
| 37 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.93265793 |
| 38 | Enlarged kidneys (HP:0000105) | 2.92880366 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.84954452 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 2.84305224 |
| 41 | Hyperglycinuria (HP:0003108) | 2.77455722 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.77447255 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.77196371 |
| 44 | Neck muscle weakness (HP:0000467) | 2.77065251 |
| 45 | Ventricular tachycardia (HP:0004756) | 2.76951314 |
| 46 | Progressive macrocephaly (HP:0004481) | 2.70215917 |
| 47 | Bundle branch block (HP:0011710) | 2.68907104 |
| 48 | Abnormality of the renal cortex (HP:0011035) | 2.66598335 |
| 49 | Epidermoid cyst (HP:0200040) | 2.62797513 |
| 50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58941073 |
| 51 | Palpitations (HP:0001962) | 2.57280899 |
| 52 | Aplasia cutis congenita (HP:0001057) | 2.55144098 |
| 53 | Difficulty running (HP:0009046) | 2.53492647 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.53371055 |
| 55 | Neoplasm of the adrenal gland (HP:0100631) | 2.52213397 |
| 56 | Thyroid-stimulating hormone excess (HP:0002925) | 2.52198093 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49538795 |
| 58 | Deep venous thrombosis (HP:0002625) | 2.49159650 |
| 59 | Parakeratosis (HP:0001036) | 2.49087300 |
| 60 | Acute necrotizing encephalopathy (HP:0006965) | 2.46979065 |
| 61 | Xanthomatosis (HP:0000991) | 2.46876473 |
| 62 | Myopathic facies (HP:0002058) | 2.46149603 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.43662288 |
| 64 | Pigmentary retinal degeneration (HP:0001146) | 2.43454892 |
| 65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.43250352 |
| 66 | Decreased central vision (HP:0007663) | 2.42995341 |
| 67 | Asymmetric septal hypertrophy (HP:0001670) | 2.42540475 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 2.42139699 |
| 69 | Hypoalphalipoproteinemia (HP:0003233) | 2.42133907 |
| 70 | Hypophosphatemic rickets (HP:0004912) | 2.41636130 |
| 71 | Prostate neoplasm (HP:0100787) | 2.41351556 |
| 72 | Chromsome breakage (HP:0040012) | 2.38899385 |
| 73 | Complement deficiency (HP:0004431) | 2.36381843 |
| 74 | Febrile seizures (HP:0002373) | 2.34794782 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.33358229 |
| 76 | Symptomatic seizures (HP:0011145) | 2.32810179 |
| 77 | Submucous cleft hard palate (HP:0000176) | 2.31903264 |
| 78 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.30269739 |
| 79 | Fair hair (HP:0002286) | 2.30226383 |
| 80 | Alveolar cell carcinoma (HP:0006519) | 2.28799438 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.27377361 |
| 82 | Chest pain (HP:0100749) | 2.26962147 |
| 83 | Myocardial infarction (HP:0001658) | 2.26442321 |
| 84 | Absent phalangeal crease (HP:0006109) | 2.26410994 |
| 85 | EMG: neuropathic changes (HP:0003445) | 2.25606463 |
| 86 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25267664 |
| 87 | Generalized hypopigmentation of hair (HP:0011358) | 2.23474114 |
| 88 | Round ear (HP:0100830) | 2.23043510 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21661235 |
| 90 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.21396395 |
| 91 | Calcaneovalgus deformity (HP:0001848) | 2.19456940 |
| 92 | Dilated cardiomyopathy (HP:0001644) | 2.17902840 |
| 93 | Acute encephalopathy (HP:0006846) | 2.17803002 |
| 94 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.17256006 |
| 95 | Abnormality of glycine metabolism (HP:0010895) | 2.17256006 |
| 96 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16765222 |
| 97 | White forelock (HP:0002211) | 2.16679938 |
| 98 | Recurrent corneal erosions (HP:0000495) | 2.16602180 |
| 99 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.15447654 |
| 100 | Abnormality of the nasal septum (HP:0000419) | 2.14451136 |
| 101 | Duplicated collecting system (HP:0000081) | 2.13667479 |
| 102 | Dyschromatopsia (HP:0007641) | 2.12716675 |
| 103 | Mitochondrial inheritance (HP:0001427) | 2.09694202 |
| 104 | Ectropion (HP:0000656) | 2.08654202 |
| 105 | Deformed tarsal bones (HP:0008119) | 2.07688737 |
| 106 | Hypolipoproteinemia (HP:0010981) | 2.07286628 |
| 107 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.06796471 |
| 108 | Thyroid carcinoma (HP:0002890) | 2.06173218 |
| 109 | Abnormality of the renal collecting system (HP:0004742) | 2.05468252 |
| 110 | Hypoplasia of the fovea (HP:0007750) | 2.04528809 |
| 111 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.04528809 |
| 112 | Patchy hypopigmentation of hair (HP:0011365) | 2.04078331 |
| 113 | Pheochromocytoma (HP:0002666) | 2.02880124 |
| 114 | Generalized aminoaciduria (HP:0002909) | 2.02466915 |
| 115 | Dry hair (HP:0011359) | 2.02364115 |
| 116 | Neoplasm of the adrenal cortex (HP:0100641) | 2.01281627 |
| 117 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01095345 |
| 118 | Increased hepatocellular lipid droplets (HP:0006565) | 2.00689531 |
| 119 | Recurrent abscess formation (HP:0002722) | 1.99161417 |
| 120 | Proximal tubulopathy (HP:0000114) | 1.98664654 |
| 121 | Papillary thyroid carcinoma (HP:0002895) | 1.97836117 |
| 122 | Muscle stiffness (HP:0003552) | 1.97245015 |
| 123 | Chronic diarrhea (HP:0002028) | 1.96962353 |
| 124 | Ketoacidosis (HP:0001993) | 1.96769063 |
| 125 | Ketosis (HP:0001946) | 1.96725863 |
| 126 | Abnormality of the columella (HP:0009929) | 1.96546116 |
| 127 | Bile duct proliferation (HP:0001408) | 1.95888347 |
| 128 | Abnormal biliary tract physiology (HP:0012439) | 1.95888347 |
| 129 | Arterial thrombosis (HP:0004420) | 1.95817960 |
| 130 | Exertional dyspnea (HP:0002875) | 1.95708464 |
| 131 | Upper limb muscle weakness (HP:0003484) | 1.95667428 |
| 132 | Heart block (HP:0012722) | 1.95635401 |
| 133 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92864060 |
| 134 | Frequent falls (HP:0002359) | 1.92587729 |
| 135 | Distal lower limb muscle weakness (HP:0009053) | 1.91730206 |
| 136 | Increased CSF lactate (HP:0002490) | 1.91024093 |
| 137 | Hypobetalipoproteinemia (HP:0003563) | 1.90913719 |
| 138 | Lipid accumulation in hepatocytes (HP:0006561) | 1.90756528 |
| 139 | Hypothermia (HP:0002045) | 1.90414351 |
| 140 | Ulnar deviation of the wrist (HP:0003049) | 1.89161015 |
| 141 | Recurrent bacterial skin infections (HP:0005406) | 1.88905371 |
| 142 | Abnormal finger flexion creases (HP:0006143) | 1.88070035 |
| 143 | Abnormality of proline metabolism (HP:0010907) | 1.87947295 |
| 144 | Hydroxyprolinuria (HP:0003080) | 1.87947295 |
| 145 | Stomatitis (HP:0010280) | 1.87210853 |
| 146 | Increased muscle lipid content (HP:0009058) | 1.87021788 |
| 147 | Acute hepatic failure (HP:0006554) | 1.86983685 |
| 148 | Hyperglycinemia (HP:0002154) | 1.86863002 |
| 149 | Exercise intolerance (HP:0003546) | 1.86630653 |
| 150 | Nasolacrimal duct obstruction (HP:0000579) | 1.86318122 |
| 151 | Hepatic necrosis (HP:0002605) | 1.86181002 |
| 152 | Metabolic acidosis (HP:0001942) | 1.85884128 |
| 153 | Cerebral edema (HP:0002181) | 1.85039641 |
| 154 | Gingival bleeding (HP:0000225) | 1.84366731 |
| 155 | Cheilitis (HP:0100825) | 1.83501856 |
| 156 | Neuroendocrine neoplasm (HP:0100634) | 1.83414546 |
| 157 | Fat malabsorption (HP:0002630) | 1.82962549 |
| 158 | Tetraparesis (HP:0002273) | 1.82642528 |
| 159 | Conjunctival hamartoma (HP:0100780) | 1.80187908 |
| 160 | Neonatal hypoglycemia (HP:0001998) | 1.79653219 |
| 161 | Lipoatrophy (HP:0100578) | 1.79363731 |
| 162 | Chorioretinal atrophy (HP:0000533) | 1.78848363 |
| 163 | Abnormality of serum amino acid levels (HP:0003112) | 1.78422008 |
| 164 | Opisthotonus (HP:0002179) | 1.78083118 |
| 165 | Rickets (HP:0002748) | 1.77657718 |
| 166 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.76612606 |
| 167 | Dicarboxylic aciduria (HP:0003215) | 1.76612606 |
| 168 | Agammaglobulinemia (HP:0004432) | 1.76421946 |
| 169 | Malignant hyperthermia (HP:0002047) | 1.76121247 |
| 170 | Hyperammonemia (HP:0001987) | 1.75234627 |
| 171 | Septo-optic dysplasia (HP:0100842) | 1.74916746 |
| 172 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74325549 |
| 173 | Nausea (HP:0002018) | 1.73653118 |
| 174 | Thyroiditis (HP:0100646) | 1.73378377 |
| 175 | Renal Fanconi syndrome (HP:0001994) | 1.72642474 |
| 176 | Hypochromic microcytic anemia (HP:0004840) | 1.72556363 |
| 177 | Tinnitus (HP:0000360) | 1.72133521 |
| 178 | Ventricular arrhythmia (HP:0004308) | 1.71848201 |
| 179 | Meningioma (HP:0002858) | 1.71048567 |
| 180 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70927363 |
| 181 | Abnormality of dental color (HP:0011073) | 1.70827179 |
| 182 | Generalized muscle weakness (HP:0003324) | 1.70799069 |
| 183 | Abnormality of nucleobase metabolism (HP:0010932) | 1.69694172 |
| 184 | Corneal dystrophy (HP:0001131) | 1.69646682 |
| 185 | Fatigue (HP:0012378) | 1.68651456 |
| 186 | True hermaphroditism (HP:0010459) | 1.68625182 |
| 187 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.68544545 |
| 188 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.65672367 |
| 189 | Myotonia (HP:0002486) | 1.63787203 |
| 190 | Lactic acidosis (HP:0003128) | 1.62989920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.46764642 |
| 2 | MKNK2 | 3.99600554 |
| 3 | INSRR | 3.94186577 |
| 4 | MAP3K12 | 3.46908727 |
| 5 | MAP3K14 | 2.59367431 |
| 6 | ZAK | 2.47093512 |
| 7 | CASK | 2.44448962 |
| 8 | MKNK1 | 2.40194987 |
| 9 | SIK3 | 2.33494658 |
| 10 | RIPK4 | 2.31797631 |
| 11 | IRAK3 | 2.29034372 |
| 12 | TTN | 2.25113377 |
| 13 | PHKG2 | 2.22552263 |
| 14 | PHKG1 | 2.22552263 |
| 15 | TXK | 2.04992360 |
| 16 | SCYL2 | 2.01361191 |
| 17 | NEK1 | 1.96175549 |
| 18 | EIF2AK3 | 1.91435664 |
| 19 | FRK | 1.86964915 |
| 20 | CDK19 | 1.86400162 |
| 21 | GRK1 | 1.83989961 |
| 22 | EIF2AK1 | 1.83463033 |
| 23 | SIK1 | 1.74877579 |
| 24 | MAP2K7 | 1.72467928 |
| 25 | ADRBK2 | 1.67526359 |
| 26 | EIF2AK2 | 1.63774658 |
| 27 | EPHB2 | 1.57863779 |
| 28 | TRPM7 | 1.53714760 |
| 29 | STK16 | 1.53023535 |
| 30 | BMPR1B | 1.48042024 |
| 31 | NUAK1 | 1.45786792 |
| 32 | MAP2K4 | 1.42215221 |
| 33 | MAPK7 | 1.37391093 |
| 34 | SGK2 | 1.33950235 |
| 35 | STK24 | 1.31080464 |
| 36 | STK38L | 1.30371986 |
| 37 | PIK3CA | 1.26702577 |
| 38 | NEK6 | 1.23828646 |
| 39 | YES1 | 1.21281209 |
| 40 | TIE1 | 1.19722430 |
| 41 | MAP2K3 | 1.18641429 |
| 42 | PINK1 | 1.17924008 |
| 43 | PLK4 | 1.16365167 |
| 44 | IRAK4 | 1.15553591 |
| 45 | GRK7 | 1.14408866 |
| 46 | CDK3 | 1.11143252 |
| 47 | FES | 1.10073864 |
| 48 | BLK | 1.08186524 |
| 49 | NLK | 1.06731339 |
| 50 | PRPF4B | 1.06217442 |
| 51 | SYK | 1.00785881 |
| 52 | TNK2 | 1.00180468 |
| 53 | LATS1 | 0.98465192 |
| 54 | IKBKE | 0.96391208 |
| 55 | MYLK | 0.96047631 |
| 56 | CCNB1 | 0.94812064 |
| 57 | PRKAA2 | 0.94479775 |
| 58 | SGK3 | 0.93538337 |
| 59 | OXSR1 | 0.91795429 |
| 60 | TAOK3 | 0.89850913 |
| 61 | MAP3K5 | 0.88733503 |
| 62 | GRK6 | 0.88169969 |
| 63 | RPS6KA4 | 0.87258634 |
| 64 | SGK223 | 0.87011368 |
| 65 | SGK494 | 0.87011368 |
| 66 | BRD4 | 0.85515234 |
| 67 | PLK3 | 0.85441990 |
| 68 | AKT3 | 0.84645283 |
| 69 | BUB1 | 0.83331556 |
| 70 | PRKCE | 0.82928036 |
| 71 | MAPK13 | 0.80017427 |
| 72 | PDK2 | 0.79837734 |
| 73 | DYRK3 | 0.75795521 |
| 74 | IKBKB | 0.75200884 |
| 75 | MAP3K2 | 0.75026000 |
| 76 | JAK1 | 0.74812970 |
| 77 | KIT | 0.73766942 |
| 78 | BCKDK | 0.73241181 |
| 79 | TAOK2 | 0.72492580 |
| 80 | PKN1 | 0.72319251 |
| 81 | IRAK1 | 0.71031377 |
| 82 | FGFR2 | 0.70709881 |
| 83 | JAK2 | 0.70386971 |
| 84 | BMPR2 | 0.69499521 |
| 85 | MUSK | 0.69036244 |
| 86 | EPHA3 | 0.68563035 |
| 87 | TGFBR2 | 0.68534034 |
| 88 | BRSK2 | 0.67398947 |
| 89 | NEK9 | 0.66015493 |
| 90 | TYK2 | 0.65935515 |
| 91 | MAP3K7 | 0.64145273 |
| 92 | ROCK1 | 0.63941767 |
| 93 | NTRK3 | 0.62201226 |
| 94 | STK4 | 0.62123950 |
| 95 | FGFR4 | 0.60881022 |
| 96 | FGFR3 | 0.59733201 |
| 97 | ERBB4 | 0.59608411 |
| 98 | TEC | 0.59575283 |
| 99 | SIK2 | 0.58885298 |
| 100 | BTK | 0.58416039 |
| 101 | SGK1 | 0.57551701 |
| 102 | VRK1 | 0.57512139 |
| 103 | JAK3 | 0.56994455 |
| 104 | TRIM28 | 0.56209409 |
| 105 | OBSCN | 0.53533088 |
| 106 | FLT3 | 0.53524642 |
| 107 | ERBB3 | 0.53257013 |
| 108 | RPS6KB2 | 0.52228351 |
| 109 | MAPK12 | 0.51822800 |
| 110 | CAMK1D | 0.51732064 |
| 111 | PRKCQ | 0.51016684 |
| 112 | MAP3K6 | 0.50987568 |
| 113 | CHUK | 0.50208146 |
| 114 | CAMKK2 | 0.49020221 |
| 115 | HCK | 0.48658295 |
| 116 | PLK2 | 0.48294702 |
| 117 | MST1R | 0.48049902 |
| 118 | IGF1R | 0.47748849 |
| 119 | PRKCG | 0.47358366 |
| 120 | CDK8 | 0.44313422 |
| 121 | CAMK4 | 0.44236049 |
| 122 | RPS6KB1 | 0.43987193 |
| 123 | PIK3CG | 0.43079876 |
| 124 | LYN | 0.42390450 |
| 125 | LRRK2 | 0.41629297 |
| 126 | CAMK1G | 0.41628553 |
| 127 | MST4 | 0.40716223 |
| 128 | CSK | 0.40190209 |
| 129 | MAPK15 | 0.39964969 |
| 130 | ADRBK1 | 0.39146094 |
| 131 | IRAK2 | 0.38701152 |
| 132 | WNK3 | 0.38048464 |
| 133 | STK3 | 0.36925250 |
| 134 | PRKG1 | 0.34759401 |
| 135 | ILK | 0.34620739 |
| 136 | MAPK11 | 0.34152002 |
| 137 | ERBB2 | 0.33891935 |
| 138 | VRK2 | 0.33767996 |
| 139 | CDK9 | 0.33266380 |
| 140 | TBK1 | 0.32373947 |
| 141 | WNK1 | 0.31377424 |
| 142 | SRPK1 | 0.31296876 |
| 143 | PRKACB | 0.31283354 |
| 144 | PRKAA1 | 0.30634128 |
| 145 | PRKACA | 0.30492096 |
| 146 | FER | 0.30271541 |
| 147 | PBK | 0.30266550 |
| 148 | PDK1 | 0.28064803 |
| 149 | RPS6KA5 | 0.27632376 |
| 150 | MAP3K1 | 0.27253784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.85272251 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.83601935 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.65828278 |
| 4 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58085047 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46356080 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.40478735 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36036360 |
| 8 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.28203431 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.23719682 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.21199765 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.20109995 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.17642712 |
| 13 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.16251667 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13196093 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.11860102 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.10776701 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.06140420 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.03216898 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.01932431 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98583561 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96558993 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.94141906 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93772874 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93392116 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91591203 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90517401 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87378690 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86548294 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.84367969 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.83557477 |
| 31 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.80649313 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.79488697 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.71460576 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.62711580 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.60758041 |
| 36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.59640145 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.58532506 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.56165897 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.53398531 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49779425 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48595605 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48337665 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.45416933 |
| 44 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.43764383 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.40879745 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.37388836 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35130237 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.29785377 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29178095 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27957996 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.24584476 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20583937 |
| 53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18671334 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16139974 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.13663197 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12676126 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.10179606 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08900211 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08374060 |
| 60 | * Lysine degradation_Homo sapiens_hsa00310 | 1.07466909 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05044939 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98071831 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97390145 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94847516 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.94305833 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89265439 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 0.88913432 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86571166 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.85011987 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84749486 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84352525 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82050945 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81598794 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81492310 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78964647 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 0.78953630 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77929867 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77204414 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74080039 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71954842 |
| 81 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70811280 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68683268 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68609462 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68470295 |
| 85 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68279311 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68059635 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.66461818 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.66249432 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65549597 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65309253 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64137482 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63989618 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63314185 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62960617 |
| 95 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62197819 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61601999 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61181079 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61166252 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61049548 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60544261 |
| 101 | Protein export_Homo sapiens_hsa03060 | 0.60142233 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57964355 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57717010 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.56427627 |
| 105 | RNA degradation_Homo sapiens_hsa03018 | 0.55690658 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55148808 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.53610917 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51073012 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50810465 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50763071 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49166209 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47412068 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47201811 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46194936 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44883845 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44746589 |
| 117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44080441 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.43828872 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.42217901 |
| 120 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.41145252 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40692223 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40275998 |
| 123 | Mismatch repair_Homo sapiens_hsa03430 | 0.40012528 |
| 124 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39321535 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.37698192 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.36498248 |
| 127 | Measles_Homo sapiens_hsa05162 | 0.33994736 |
| 128 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.32691324 |
| 129 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32072005 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31970740 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31394573 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.31176501 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29800069 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29537799 |
| 135 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.28352126 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28038132 |
| 137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.28009322 |
| 138 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.26531678 |
| 139 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.25953309 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.25511763 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.24901708 |
| 142 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23289310 |
| 143 | Nicotine addiction_Homo sapiens_hsa05033 | 0.22904773 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22695396 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22533779 |

